itmn

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Recent 52-Week High Exceeded in Shares o...

Smith & Wesson (NASDAQ:SWHC) traded at a new 52-week high today of $18.74. Approximate ...

Sempra Energy: The Losing Streak Continu...

Shares of Sempra Energy (NYSE:SRE) traded at a new 52-week low today of $93.04. Approx ...

Senior Housing Properties Trust: The Los...

Senior Housing Properties Trust (NYSE:SNH) traded at a new 52-week low today of $15.35. ...

Sharps Compliance: 52-Week High Recently...

Shares of Sharps Compliance (NASDAQ:SMED) traded today at $7.55, breaking its 52-week h ...

Plum Creek Timber Looks to Continue to T...

Plum Creek Timber (NYSE:PCL) traded at a new 52-week low today of $37.85. Approximatel ...

Potlatch: The Losing Streak Continues (P...

Shares of Potlatch (NYSE:PCH) traded today at $32.54, breaking its 52-week low. This n ...

Shares of Corporate Office Properties Tr...

Corporate Office Properties Trust (NYSE:OFC) traded today at a new 52-week low of $20.6 ...

National Health Investors: New 52-Week L...

Shares of National Health Investors (NYSE:NHI) traded today at $54.19, breaking its 52- ...

Most Popular Video News